{
  "success": true,
  "pagesUsed": [
    1,
    5,
    15
  ],
  "modelUsed": "gemini-3-flash-preview",
  "narrative": {
    "narrativeContents": [
      {
        "id": "nc_1",
        "name": "PROTOCOL SYNOPSIS",
        "text": "PROTOCOL SYNOPSIS",
        "order": 0,
        "instanceType": "NarrativeContent",
        "sectionNumber": "0",
        "sectionTitle": "PROTOCOL SYNOPSIS",
        "sectionType": {
          "id": "4a00de62-c9a9-4720-b64b-95a3f0c0a1dc",
          "code": "Synopsis",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Synopsis",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_2",
        "name": "INTRODUCTION",
        "text": "INTRODUCTION",
        "order": 1,
        "instanceType": "NarrativeContent",
        "sectionNumber": "1",
        "sectionTitle": "INTRODUCTION",
        "sectionType": {
          "id": "56d073f4-2dff-495f-b202-04f6241dc4de",
          "code": "Introduction",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Introduction",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_2_1",
          "nci_2_2",
          "nci_2_3",
          "nci_2_4",
          "nci_2_5",
          "nci_2_6",
          "nci_2_7",
          "nci_2_8"
        ]
      },
      {
        "id": "nc_3",
        "name": "OBJECTIVES",
        "text": "OBJECTIVES",
        "order": 2,
        "instanceType": "NarrativeContent",
        "sectionNumber": "2",
        "sectionTitle": "OBJECTIVES",
        "sectionType": {
          "id": "dde52303-23b6-4201-8740-081ef372001c",
          "code": "Objectives",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Objectives",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_4",
        "name": "STUDY DESIGN",
        "text": "STUDY DESIGN",
        "order": 3,
        "instanceType": "NarrativeContent",
        "sectionNumber": "3",
        "sectionTitle": "STUDY DESIGN",
        "sectionType": {
          "id": "78eea7b9-58d4-4b3e-a838-5504d143ee4e",
          "code": "Study Design",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Design",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_4_1",
          "nci_4_2",
          "nci_4_3",
          "nci_4_4",
          "nci_4_5"
        ]
      },
      {
        "id": "nc_5",
        "name": "SUBJECT POPULATION",
        "text": "SUBJECT POPULATION",
        "order": 4,
        "instanceType": "NarrativeContent",
        "sectionNumber": "4",
        "sectionTitle": "SUBJECT POPULATION",
        "sectionType": {
          "id": "bb6c0bcd-1fdf-49e6-9ba2-cc67584efe5d",
          "code": "Study Population",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Population",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_5_1",
          "nci_5_2",
          "nci_5_3"
        ]
      },
      {
        "id": "nc_6",
        "name": "INVESTIGATIONAL MEDICINAL PRODUCTS",
        "text": "INVESTIGATIONAL MEDICINAL PRODUCTS",
        "order": 5,
        "instanceType": "NarrativeContent",
        "sectionNumber": "5",
        "sectionTitle": "INVESTIGATIONAL MEDICINAL PRODUCTS",
        "sectionType": {
          "id": "aa583b11-0113-4376-98d5-93bd0fbb1bab",
          "code": "Treatment",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Treatment",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_6_1"
        ]
      }
    ],
    "narrativeContentItems": [
      {
        "id": "nci_2_1",
        "name": "Background",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.1",
        "sectionTitle": "Background"
      },
      {
        "id": "nci_2_2",
        "name": "Selonsertib (SEL)",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.2",
        "sectionTitle": "Selonsertib (SEL)"
      },
      {
        "id": "nci_2_3",
        "name": "GS-0976",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.3",
        "sectionTitle": "GS-0976"
      },
      {
        "id": "nci_2_4",
        "name": "GS-9674",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.4",
        "sectionTitle": "GS-9674"
      },
      {
        "id": "nci_2_5",
        "name": "Combination Studies of SEL, GS-0976, and GS-9674",
        "text": "",
        "order": 4,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.5",
        "sectionTitle": "Combination Studies of SEL, GS-0976, and GS-9674"
      },
      {
        "id": "nci_2_6",
        "name": "Rationale for This Study",
        "text": "",
        "order": 5,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.6",
        "sectionTitle": "Rationale for This Study"
      },
      {
        "id": "nci_2_7",
        "name": "Risk/Benefit Assessment for the Study",
        "text": "",
        "order": 6,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.7",
        "sectionTitle": "Risk/Benefit Assessment for the Study"
      },
      {
        "id": "nci_2_8",
        "name": "Compliance",
        "text": "",
        "order": 7,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.8",
        "sectionTitle": "Compliance"
      },
      {
        "id": "nci_4_1",
        "name": "Study Design",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.1",
        "sectionTitle": "Study Design"
      },
      {
        "id": "nci_4_2",
        "name": "Study Treatments",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.2",
        "sectionTitle": "Study Treatments"
      },
      {
        "id": "nci_4_3",
        "name": "Duration of Study",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.3",
        "sectionTitle": "Duration of Study"
      },
      {
        "id": "nci_4_4",
        "name": "End of Study",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.4",
        "sectionTitle": "End of Study"
      },
      {
        "id": "nci_4_5",
        "name": "Post Stud Cru·e",
        "text": "",
        "order": 4,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.5",
        "sectionTitle": "Post Stud Cru·e"
      },
      {
        "id": "nci_5_1",
        "name": "Number of Subjects and Subject Select.ion",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.1",
        "sectionTitle": "Number of Subjects and Subject Select.ion"
      },
      {
        "id": "nci_5_2",
        "name": "Inclusion Criteria",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.2",
        "sectionTitle": "Inclusion Criteria"
      },
      {
        "id": "nci_5_3",
        "name": "Exclusion Criteria",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.3",
        "sectionTitle": "Exclusion Criteria"
      },
      {
        "id": "nci_6_1",
        "name": "Randomization, Blinding and Treatment Codes",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.1",
        "sectionTitle": "Randomization, Blinding and Treatment Codes"
      }
    ],
    "abbreviations": [
      {
        "id": "abbr_1",
        "abbreviatedText": "SEL",
        "expandedText": "selonsertib",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_2",
        "abbreviatedText": "NASH",
        "expandedText": "Nonalcoholic Steatohepatitis",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_3",
        "abbreviatedText": "CRN",
        "expandedText": "Clinical Research Network",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_4",
        "abbreviatedText": "-SMA",
        "expandedText": "alpha smooth muscle actin",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_5",
        "abbreviatedText": "g",
        "expandedText": "Microgram",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_6",
        "abbreviatedText": "ACC",
        "expandedText": "acetyl-CoA carboxylase",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_7",
        "abbreviatedText": "AE",
        "expandedText": "adverse event",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_8",
        "abbreviatedText": "AH",
        "expandedText": "alcoholic hepatitis",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_9",
        "abbreviatedText": "AICD",
        "expandedText": "automatic implantable cardioverter defibrillator",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_10",
        "abbreviatedText": "aPTT",
        "expandedText": "activated partial thromboplastin time",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_11",
        "abbreviatedText": "ASK1",
        "expandedText": "apoptosis signal-regulating kinase 1",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_12",
        "abbreviatedText": "AUC",
        "expandedText": "area under the plasma/serum concentration versus time curve",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_13",
        "abbreviatedText": "AUC2-12hr",
        "expandedText": "partial area under the plasma/serum concentration versus time curve from time 2 to time 12",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_14",
        "abbreviatedText": "AUC24hr",
        "expandedText": "area under the plasma/serum concentration versus time curve from time zero to time 24",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_15",
        "abbreviatedText": "AUCinf",
        "expandedText": "area under the plasma/serum concentration versus time curve extrapolated to infinite time, calculated as AUC0last + (Clast/z)",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_16",
        "abbreviatedText": "AUClast",
        "expandedText": "area under the plasma/serum concentration versus time curve from time zero to the last quantifiable concentration",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_17",
        "abbreviatedText": "AUCtau",
        "expandedText": "area under the plasma/serum concentration versus time curve from time zero to the last quantifiable concentration",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_18",
        "abbreviatedText": "BAP",
        "expandedText": "Biomarker Analysis Plan",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_19",
        "abbreviatedText": "BID",
        "expandedText": "twice daily",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_20",
        "abbreviatedText": "BL",
        "expandedText": "Baseline",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_21",
        "abbreviatedText": "BMI",
        "expandedText": "body mass index",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_22",
        "abbreviatedText": "BUN",
        "expandedText": "blood urea nitrogen",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_23",
        "abbreviatedText": "CAP",
        "expandedText": "controlled attenuation parameter",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_24",
        "abbreviatedText": "CCR",
        "expandedText": "Chemokine Receptor",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_25",
        "abbreviatedText": "CDHFD",
        "expandedText": "choline-deficient high-fat diet",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_26",
        "abbreviatedText": "CFR",
        "expandedText": "Code of Federal Regulations",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_27",
        "abbreviatedText": "CI",
        "expandedText": "confidence interval",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_28",
        "abbreviatedText": "c-Jun",
        "expandedText": "c-Jun protein",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_29",
        "abbreviatedText": "CK 18",
        "expandedText": "cytokeratin 18",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_30",
        "abbreviatedText": "Clast",
        "expandedText": "last observed quantifiable plasma/serum concentration of the drug",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_31",
        "abbreviatedText": "CLcr",
        "expandedText": "creatinine clearance",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_32",
        "abbreviatedText": "CLDQ-NAFLD",
        "expandedText": "Chronic Liver Disease Questionnaire-Nonalcoholic Fatty Liver Disease",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_33",
        "abbreviatedText": "Cmax",
        "expandedText": "maximum observed plasma/serum concentration of drug",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_34",
        "abbreviatedText": "CMH",
        "expandedText": "Cochran-Mantel-Haenszel",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_35",
        "abbreviatedText": "COL1A1",
        "expandedText": "collagen type 1 alpha 1",
        "instanceType": "Abbreviation"
      }
    ],
    "summary": {
      "sectionCount": 6,
      "itemCount": 17,
      "abbreviationCount": 35
    },
    "studyDefinitionDocument": {
      "id": "sdd_1",
      "name": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib, GS-0976, GS-9674, and Combinations in Subjects with Bridging (F3) Fibrosis or Compensated Cirrhosis (F4) due to Nonalcoholic Steatohepatitis (NASH)",
      "documentType": "Protocol",
      "language": "en",
      "instanceType": "StudyDefinitionDocument",
      "version": "Amendment 4",
      "versionDate": "25 April 2019",
      "contentIds": [
        "nc_1",
        "nc_2",
        "nc_3",
        "nc_4",
        "nc_5",
        "nc_6"
      ]
    }
  },
  "rawResponse": {
    "abbreviations": {
      "abbreviations": [
        {
          "abbreviation": "SEL",
          "expansion": "selonsertib"
        },
        {
          "abbreviation": "NASH",
          "expansion": "Nonalcoholic Steatohepatitis"
        },
        {
          "abbreviation": "CRN",
          "expansion": "Clinical Research Network"
        },
        {
          "abbreviation": "-SMA",
          "expansion": "alpha smooth muscle actin"
        },
        {
          "abbreviation": "g",
          "expansion": "Microgram"
        },
        {
          "abbreviation": "ACC",
          "expansion": "acetyl-CoA carboxylase"
        },
        {
          "abbreviation": "AE",
          "expansion": "adverse event"
        },
        {
          "abbreviation": "AH",
          "expansion": "alcoholic hepatitis"
        },
        {
          "abbreviation": "AICD",
          "expansion": "automatic implantable cardioverter defibrillator"
        },
        {
          "abbreviation": "aPTT",
          "expansion": "activated partial thromboplastin time"
        },
        {
          "abbreviation": "ASK1",
          "expansion": "apoptosis signal-regulating kinase 1"
        },
        {
          "abbreviation": "AUC",
          "expansion": "area under the plasma/serum concentration versus time curve"
        },
        {
          "abbreviation": "AUC2-12hr",
          "expansion": "partial area under the plasma/serum concentration versus time curve from time 2 to time 12"
        },
        {
          "abbreviation": "AUC24hr",
          "expansion": "area under the plasma/serum concentration versus time curve from time zero to time 24"
        },
        {
          "abbreviation": "AUCinf",
          "expansion": "area under the plasma/serum concentration versus time curve extrapolated to infinite time, calculated as AUC0last + (Clast/z)"
        },
        {
          "abbreviation": "AUClast",
          "expansion": "area under the plasma/serum concentration versus time curve from time zero to the last quantifiable concentration"
        },
        {
          "abbreviation": "AUCtau",
          "expansion": "area under the plasma/serum concentration versus time curve from time zero to the last quantifiable concentration"
        },
        {
          "abbreviation": "BAP",
          "expansion": "Biomarker Analysis Plan"
        },
        {
          "abbreviation": "BID",
          "expansion": "twice daily"
        },
        {
          "abbreviation": "BL",
          "expansion": "Baseline"
        },
        {
          "abbreviation": "BMI",
          "expansion": "body mass index"
        },
        {
          "abbreviation": "BUN",
          "expansion": "blood urea nitrogen"
        },
        {
          "abbreviation": "CAP",
          "expansion": "controlled attenuation parameter"
        },
        {
          "abbreviation": "CCR",
          "expansion": "Chemokine Receptor"
        },
        {
          "abbreviation": "CDHFD",
          "expansion": "choline-deficient high-fat diet"
        },
        {
          "abbreviation": "CFR",
          "expansion": "Code of Federal Regulations"
        },
        {
          "abbreviation": "CI",
          "expansion": "confidence interval"
        },
        {
          "abbreviation": "c-Jun",
          "expansion": "c-Jun protein"
        },
        {
          "abbreviation": "CK 18",
          "expansion": "cytokeratin 18"
        },
        {
          "abbreviation": "Clast",
          "expansion": "last observed quantifiable plasma/serum concentration of the drug"
        },
        {
          "abbreviation": "CLcr",
          "expansion": "creatinine clearance"
        },
        {
          "abbreviation": "CLDQ-NAFLD",
          "expansion": "Chronic Liver Disease Questionnaire-Nonalcoholic Fatty Liver Disease"
        },
        {
          "abbreviation": "Cmax",
          "expansion": "maximum observed plasma/serum concentration of drug"
        },
        {
          "abbreviation": "CMH",
          "expansion": "Cochran-Mantel-Haenszel"
        },
        {
          "abbreviation": "COL1A1",
          "expansion": "collagen type 1 alpha 1"
        }
      ]
    },
    "structure": {
      "document": {
        "title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib, GS-0976, GS-9674, and Combinations in Subjects with Bridging (F3) Fibrosis or Compensated Cirrhosis (F4) due to Nonalcoholic Steatohepatitis (NASH)",
        "version": "Amendment 4",
        "versionDate": "25 April 2019"
      },
      "sections": [
        {
          "number": "0",
          "title": "PROTOCOL SYNOPSIS",
          "type": "Synopsis"
        },
        {
          "number": "1",
          "title": "INTRODUCTION",
          "type": "Introduction",
          "subsections": [
            {
              "number": "1.1",
              "title": "Background"
            },
            {
              "number": "1.2",
              "title": "Selonsertib (SEL)",
              "subsections": [
                {
                  "number": "1.2.1",
                  "title": "General Infonnation for SEL"
                },
                {
                  "number": "1.2.2",
                  "title": "Nonclinical Phrumacology and Toxicology"
                },
                {
                  "number": "1.2.3",
                  "title": "Clinical Trials ofSEL"
                }
              ]
            },
            {
              "number": "1.3",
              "title": "GS-0976",
              "subsections": [
                {
                  "number": "1.3.1",
                  "title": "General Infonnation for GS-0976"
                },
                {
                  "number": "1.3.2",
                  "title": "Nonclinical Phrumacology and Toxicology"
                },
                {
                  "number": "1.3.3",
                  "title": "Clinical Trials ofGS-0976"
                }
              ]
            },
            {
              "number": "1.4",
              "title": "GS-9674",
              "subsections": [
                {
                  "number": "1.4.1",
                  "title": "General Infonnation for GS-9674"
                },
                {
                  "number": "1.4.2",
                  "title": "Nonclinical Phrumacology and Toxicology"
                },
                {
                  "number": "1.4.3",
                  "title": "Clinical Trials ofGS-9674"
                }
              ]
            },
            {
              "number": "1.5",
              "title": "Combination Studies of SEL, GS-0976, and GS-9674",
              "subsections": [
                {
                  "number": "1.5.1",
                  "title": "Nonclinical Pha1macology, Phrumacokinetics, Drng Metabolism, and Toxicology"
                },
                {
                  "number": "1.5.2",
                  "title": "Clinical Trials"
                }
              ]
            },
            {
              "number": "1.6",
              "title": "Rationale for This Study",
              "subsections": [
                {
                  "number": "1.6.1",
                  "title": "Rationale for Dose Selection of SEL."
                },
                {
                  "number": "1.6.2",
                  "title": "Rationale for Dose Selection of GS-0976"
                },
                {
                  "number": "1.6.3",
                  "title": "Rationale for Dose Selection of GS-9674"
                },
                {
                  "number": "1.6.4",
                  "title": "Rationale for Dose Selection of Combinations"
                }
              ]
            },
            {
              "number": "1.7",
              "title": "Risk/Benefit Assessment for the Study"
            },
            {
              "number": "1.8",
              "title": "Compliance"
            }
          ]
        },
        {
          "number": "2",
          "title": "OBJECTIVES",
          "type": "Objectives"
        },
        {
          "number": "3",
          "title": "STUDY DESIGN",
          "type": "Study Design",
          "subsections": [
            {
              "number": "3.1",
              "title": "Study Design"
            },
            {
              "number": "3.2",
              "title": "Study Treatments"
            },
            {
              "number": "3.3",
              "title": "Duration of Study"
            },
            {
              "number": "3.4",
              "title": "End of Study"
            },
            {
              "number": "3.5",
              "title": "Post Stud Cru·e"
            }
          ]
        },
        {
          "number": "4",
          "title": "SUBJECT POPULATION",
          "type": "Study Population",
          "subsections": [
            {
              "number": "4.1",
              "title": "Number of Subjects and Subject Select.ion"
            },
            {
              "number": "4.2",
              "title": "Inclusion Criteria"
            },
            {
              "number": "4.3",
              "title": "Exclusion Criteria"
            }
          ]
        },
        {
          "number": "5",
          "title": "INVESTIGATIONAL MEDICINAL PRODUCTS",
          "type": "Treatment",
          "subsections": [
            {
              "number": "5.1",
              "title": "Randomization, Blinding and Treatment Codes"
            }
          ]
        }
      ]
    }
  }
}